Journal Mobile

SJ Leslie
Journal Issue: 
Volume 36: Issue 3: 2006




The  publication  of  a  large  number  of  randomised  controlled  trials  in heart failure patients over the last 25 years has allowed the development of several excellent  evidence-based  guidelines. Revised  SIGN guidelines  for  heart  failure are  due  for  publication  this  year. The  major  challenge  facing  us  now  is  the implementation of these evidence-based therapies and the allocation of resources to allow the development and assessment of emerging technologies to ensure that patients receive the treatments they need.